GlaxoSmithKline Nigeria

GlaxoSmithKline Consumer Nigeria PLC (GSK Nigeria) was the Nigerian subsidiary of UK-headquartered pharmaceutical and consumer healthcare giant GlaxoSmithKline PLC, listed on the Nigerian Exchange Limited until 2023. The company marketed prescription medicines, consumer healthcare products (Panadol, Sensodyne, Macleans, Horlicks), and vaccines in Nigeria. In August 2023, GSK announced its exit from Nigeria, closing its commercial operations and transitioning to a third-party distribution model, marking one of several multinational FMCG and pharmaceutical exits from Nigeria amid foreign exchange and macroeconomic challenges.